Loading organizations...
§ Private Profile · Menlo Park, CA, USA
Cancer immunotherapy company using synthetic biology and gene engineering.
Refuge Biotechnologies has raised $25.0M across 1 funding round.
Refuge Biotechnologies has raised $25.0M in total across 1 funding round.
Refuge Biotechnologies has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 2, 2018 | $25M Series B | DR. Jing LOU, Neil Shen | 3E Bioventures Capital, Danhua Capital, Ocean Pine Healthcare Fund, Sangel Capital, ShangBay Capital, WuXi Healthcare Ventures | Announced |
Refuge Biotechnologies has raised $25.0M in total across 1 funding round.
Refuge Biotechnologies's investors include Dr. Jing Lou, Neil Shen, 3E Bioventures Capital, Danhua Capital, Ocean Pine Healthcare Fund, Sangel Capital, ShangBay Capital, WuXi Healthcare Ventures.